Blockchain Registration Transaction Record

GeoVax Labs to Present Update on Mpox Vaccine Program at Emerging Growth Conference

GeoVax Labs to present at Emerging Growth Conference, providing updates on GEO-MVA for Mpox and smallpox. Learn about the company's lead clinical programs and the development of next-generation COVID-19 vaccine, GEO-CM04S1.

GeoVax Labs to Present Update on Mpox Vaccine Program at Emerging Growth Conference

This news matters as it provides insight into the latest developments in GeoVax Labs' vaccine program, including updates on GEO-MVA for Mpox and smallpox. Shareholders and the investment community will have the opportunity to interact with the company's CEO, David Dodd, and gain valuable information on the company's progress in developing novel vaccines for infectious diseases and cancers.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x440e7ca20ef578177951e5ba38576b822e00515599186e71a557de5b6c6c411b
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintquitPDBZ-b115ab62ec284c815fed4df64934cd32